×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Challenges for Stable Supply of Drugs and International Cooperation
Session Chair(s)
Nobumasa Nakashima
Health Policy Director, National Healthcare Policy Secretariat
Cabinet Office, Japan
FDA, EMA and PMDA representatives will explain the current issues and measures against drug shortages in the rapid globalization of supply chains. They will also suggest a cooperative scheme among regulatory authorities and industries to secure a stable supply of drugs.
Learning Objective : Describe the current drug supply situation in the US, Europe and Japan and the efforts made by regulators and manufacturers; Discuss possible global cooperation for a stable supply of drugs including shortage information sharing and recommendations to manufacturers.
Speaker(s)
FDA Perspective
Justina Molzon, JD, MS
Consumer Services, United States
Consumer Services
EMA Perspective
Emer Cooke, MBA, MSc
The European Medicines Agency, Netherlands
Executive Director, Chair, ICMRA
Japan Perspective
Naoyuki Yasuda, MSc
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Associate Executive Director , Office of International Programs
Have an account?